Wikidata entity: Q15708278
C₆₄₇₂H₁₀₀₂₈N₁₇₄₀O₂₀₁₄S₄₆ (P274)
Quantities
| P2067 | mass | 145912.34 |
| P790 | approved by | ... | Q204711 (United States Food and Drug Administration) | United States Food and Drug Administration |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P31 | instance of | ... | Q422248 (monoclonal antibody) | monoclonal antibody |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P2175 | medical condition treated | ... | Q11081 (Alzheimer's disease) | Alzheimer's disease |
| P129 | physically interacts with | ... | Q423510 (Amyloid beta precursor protein) | Amyloid beta precursor protein |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q422248 (monoclonal antibody) | monoclonal antibody |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | aducanumab | ??? |
| P231 | CAS Registry Number | 1384260-65-4 |
| P592 | ChEMBL ID | CHEMBL3039540 |
| P715 | DrugBank ID | DB12274 |
| P646 | Freebase ID | /m/0zmzwqq |
| P595 | Guide to Pharmacology Ligand ID | 8325 |
| P665 | KEGG ID | D10541 |
| P10245 | MedlinePlus drug identifier | a621033 |
| P2153 | PubChem Substance ID (SID) | 252166537 |
| P3417 | Quora topic ID | Aducanumab |
| P3345 | RxNorm CUI | 2557217 |
| P4527 | UK Parliament thesaurus ID | 483514 |
| P652 | UNII | 105J35OE21 |
| P11143 | WikiProjectMed ID | Aducanumab |
| P3350 | World Health Organisation international non-proprietary name numeric ID | 9838 |
Why not click here or view trends?
log id: 9682476